Cardiff Oncology CRDF
NASDAQ CRDF
$0.91 -0.02 (-2.15%)
At close: Oct 23, 2026 · 4:00 PM EDT

Cardiff Oncology (CRDF) Non Operating Investment Income (2014 - 2015)

Updated

Cardiff Oncology (CRDF) posted Non Operating Investment Income of $3,568 for Q1 2015, down 91.9% from $44,101 a year earlier.

Analysis

Cardiff Oncology (CRDF) Non Operating Investment Income (2014 - 2015) Analysis & Trends

For the trailing twelve months through Mar 31, 2015, Non Operating Investment Income at Cardiff Oncology was -$15,687; for FY2014, it came in at $24,845.

  • In prior years, Cardiff Oncology's Non Operating Investment Income was -$22,941 in FY2013 and $4,000 in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Cardiff Oncology 62.34 Mn 27.84 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 3,568.00
Sep 30, 2014 -19,255.00
Mar 31, 2014 44,101.00
API Access

Cardiff Oncology Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=CRDF&period=max&api_key=YOUR_API_KEY